7-methoxytacrine-4-pyridinealdoxime (7-MEOTA-4-PA, named hybrid 5C) is a compound formerly synthesized and evaluated in vitro, together with 4-pyridine aldoxime (4-PA) and commercial reactivators of acetylcholinesterase (AChE). This compound was designed with the purpose of being a prophylactic reactivator, capable of interacting with different subdomains of the active site of AChE. To investigate these interactions, theoretical results from docking were first compared with experimental data of hybrid 5C, 4-PA, and two commercial oximes, on the reactivation of human AChE (HssAChE) inhibited by VX. Then, further docking studies, molecular dynamics simulations, and molecular mechanics Poisson-Boltzmann surface area calculations, were carried out to investigate reactivation performances, considering the near attack conformation (NAC) approach, prior to the nucleophilic substitution mechanism. Our results helped to elucidate the interactions of such molecules with the different subdomains of the active site of HssAChE. Additionally, NAC poses of each oxime were suggested for further theoretical studies on the reactivation reaction.

b Faculty of Science Department of Chemistry University of Hradec Kralove Hradec Kralove Czech Republic

c Laboratory of Molecular Modeling Chemistry Department Federal University of Lavras Lavras Brazil

Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense Department of Chemical Engineering Military Institute of Engineering Rio de Janeiro RJ Brazil

See more in PubMed

Worek F, Thiermann H. The value of novel oximes for treatment of poisoning by organophosphorus compounds. Pharmacol Ther 2013;139:249–59. PubMed

Korabecny J, Soukup O, Dolezal R. From pyridinium-based to centrally active acetylcholinesterase reactivators. Mini Rev Med Chem 2014;14:215–21. PubMed

Antonijevic B, Stojiljkovic MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res 2007;5:71–82. PubMed PMC

Sharma R, Gupta B, Singh N, et al. . Development and structural modifications of cholinesterase reactivators against chemical warfare agents in last decade: a review. Mini Rev Med Chem 2015;15:58–72. PubMed

Gorecki L, Korabecny J, Musilek K. SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides. Arch Toxicol 2016;90:2831–59. PubMed

Nepovimova E, Korabecny J, Dolezal R, et al. . 7. Methoxytacrine – 4-pyridinealdoxime hybrid as novel prophylactic agent with reactivation properties in organophosphate intoxications. Toxicol Res (Camb) 2016;5:1012–6. PubMed PMC

Sadiq SK, Coveney PV. Computing the role of near attack conformations in an enzyme-catalyzed nucleophilic bimolecular reaction. J Chem Theory Comput 2015;11:316–24. PubMed

Ellman GL, Courtney KD, Andres VJ, et al. . A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95. PubMed

Winter M, Wille T, Musilek K, et al. . Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase. Toxicol Lett 2016;244:136–42. PubMed

Chen Y. Beware of docking! Trends Pharmacol Sci 2015;36:78–95. PubMed

Hur S, Bruice TC. The near attack conformation approach to the study of the chorismate to prephenate reaction. Proc Natl Acad Sci USA 2003;100:12015–20. PubMed PMC

Sahu AK, Gupta B, Sharma R, et al. . Kinetic and physicochemical analysis of structurally different bis-pyridinium oximes against pesticide inhibited AChE. Indian J Chem 2015;4A:40–5.

Singh N, Karpichev Y, Tiwari AK, et al. . Oxime functionality in surfactant self-assembly: an overview on combating toxicity of organophosphates. J Mol Liq 2015;208:237–52.

Deppmeier BJ, Driessen AJ, Hehre WJ, et al. PC Spartan Pro 1.0.5. Wavefunction Inc., Irvine, CA, USA; 2000.

Halgren TA, Nachbar RB. Merck molecular force field. IV. Conformational energies and geometries for MMFF94. J Comput Chem 1996;17:587–615.

Dewar MJS, Zoebisch EG, Healy EF, et al. . AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 1985;107:3902–9.

Bayly CI, Cieplak P, Cornell WD, et al. . A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model. J Phys Chem 1993;97:10269–80.

Berman HM, Westbrook J, Feng Z, et al. . The protein data bank. Nucleic Acids Res 2000;28:235–42. PubMed PMC

Artursson E, Andersson PO, Akfur C, et al. . Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity. Biochem Pharmacol 2013;85:1389–97. PubMed

BIOVIA, Dassault Systèmes. Discovery studio modeling environment. Release 4.5. Dassault Systèmes, San Diego (CA); 2015.

Boulet E, Lieberherr D, Tognolli M, et al. . UniProtKB/Swiss-Prot, the manually annotated section of the Uniprot knowledgebase: how to use the entry view. Methods Mol Biol 2016;1374:23–54. PubMed

The UniProt Consortium UniProt: the universal protein knowledgebase. Nucleic Acids Res 2017;45:D158–69. PubMed PMC

Soreq H, Ben-Aziz R, Prody CA, et al. . Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + G-rich attenuating structures. Proc Natl Acad Sci USA 1990;87:9688–92. PubMed PMC

Brooks BR, Brooks CL, Mackerell AD, et al. . CHARMM: the biomolecular simulation program. J Comput Chem 2009;30:1545–614. PubMed PMC

Best RB, Zhu X, Shim J, et al. . Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and sidechain χ1 and χ2 dihedral angles. J Comput Chem 2012;8:3257–73. PubMed PMC

Vorobyov IV, Anisimov VM, MacKerell AD. Jr.. Polarizable empirical force field for alkanes based on the classical Drude oscillator model. J Phys Chem B 2005;109:18988–99. PubMed

Macias AT, MacKerell AD. Jr.. CH/pi interactions involving aromatic amino acids: refinement of the CHARMM tryptophan force field. J Comput Chem 2005;26:1452–63. PubMed

Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem 2006;49:3315–21. PubMed

Warren GL, Webster AC, Capelli AM, et al. . A critical assessment of docking programs and scoring functions. J Med Chem 2006;49:5912–31. PubMed

Kuca K, Jun D, Junova L, et al. . Synthesis, biological evaluation, and docking studies of novel bisquaternary aldoxime reactivators on acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon. Molecules 2018;23:1103. PubMed PMC

Ashani Y, Radic Z, Tsigelny I, et al. . Taylor P amino acid residues controlling reactivation of organiphosphonyl conjugates of acetylcholinesterase by mono- and bisquarternary oximes. J Biol Chem 1995;11:6370–80. PubMed

Delfino RT, Figueroa-Villar JD. Nucleophilic reactivation of sarin-inhibited acetylcholinesterase: a molecular modeling study. J Phys Chem B 2009;113:8402–11. PubMed

Wang J, Gu J, Leszczynski J, et al. . Oxime-induced reactivation of sarin-inhibited AChE: a theoretical mechanisms study. J Phys Chem B 2007;111:2404–8. PubMed

Abraham MJ, Murtola T, Schulz R, et al. . GROMACS: high performance simulations through multi-level parallelism from laptops top supercomputers. SoftwareX 2015;1–2:19–25.

Abraham MJ, van der Spoel D, Lindahl E, et al. . The GROMACS development team. GROMACS user manual version; 2016;514.

Jorgensen WL, Maxwell DS, Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996;118:11225–36.

da Silva AWS, Vranken WF. ACPYPE—antechamber python parser interface. BMC Res Notes 2012;5:367–8. PubMed PMC

Carlson HA. Lessons learned over four benchmark exercises from the community structure-activity resource. J Chem Inf Model 2016;56:951–4. PubMed PMC

Wang J, Wang W, Kollman PA, et al. . Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 2006;25:247–60. PubMed

Ribeiro A, Horta BAC, Alencastro RB. MKTOP: a program for automatic construction of molecular topologies. J Braz Chem Soc 2008;9:1433–5.

Essmann U, Perera L, Berkowitz ML, et al. . A smooth particle mesh Ewald method. J Chem Phys 1995;103:8577–93.

Guimaraes AP, Oliveira AA, Cunha EFF, et al. . Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation. J Mol Model 2011;17:2939–51. PubMed

Silva ML, Goncalves AD, Batista PR, et al. . Franca, TCC. Design, docking studies and molecular dynamics of new potential selective inhibitors of Plasmodium falciparum serine hydroxymethyltransferase. Mol Simul 2010;36:1–4.

Franca TCC, Medeiros ALR, Santos ECP, et al. . A complete model of the Plasmodium falciparum bifunctional enzyme dihydrofolate reductase-thymidylate synthase. A model to design new antimalarials. J Braz Chem Soc 2004;15:450–4.

Berendsen HJC, Postma JPM, van Gusteren WF, et al. . Molecular dynamics with coupling to an external bath. J Chem Phys 1984;81:3684–90.

Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 1981;52:7182–90.

Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph 1996;14:33–8. PubMed

Delano WL. The PyMOL molecular graphics system. San Carlos, Palo Alto (CA): Delajno Scientific LLC; 2002.

Abascal JLF, Vega C. A general purpose model for the condensed phases of water: TIP4P/2005. J Chem Phys 2005;123:234505. PubMed

Homeyer N, Gohlke H. Free energy calculations by the molecular mechanics Poisson-Boltzmann surface area method. Mol Inform 2012;31:114–22. PubMed

Hansen N, van Gunsteren WF. Practical aspects of free-energy calculations: a review. J Chem Theory Comput 2014;10:2632–47. PubMed

Kumari R, Kumar R, Lynn A. g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 2014;54:1951–62. PubMed

Kollman PA, Massova I, Reyes C, et al. . Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res 2000;33. PubMed

Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Exp Opin Drug Discov 2015;10:449–61. PubMed PMC

Gallichio E, Kubo MM, Levy RM. Enthalpy-entropy and cavity decomposition of alkane hydration free energies: numerical results and implications for theories of hydrophobic solvation. J Phys Chem B 2000;104:6271–85.

Wagoner JA, Baker NA. Assessing implicit models for nonpolar mean solvation forces: the importance of dispersion and volume terms. Proc Natl Acad Sci USA 2006;104:8331–6. PubMed PMC

Skyner RE, McDonagh JL, Groom CR, et al. . A review of methods for the calculation of solution free energies and the modelling of systems in solution. Phys Chem Chem Phys 2015;17:6174–91. PubMed

Honig B, Nicholls A. Classical electrostatics in biology and chemistry. Science 1995;268:1144–9. PubMed

Swain M. Chemicalize.org. J Chem Inf Model 2012;52:613–5.

Bester SM, Guelta MA, Cheung J, et al. . Structural insights of stereospecific inhibition of human acetylcholinesterase by VX and subsequent reactivation by HI-6. Chem Res Toxicol 2018;31:1405. PubMed

Santoni G, de Sousa J, de la Mora E, et al. . Structure-based optimization of nonquaternary reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents. J Med Chem 2018;61:7630–9. PubMed

Katalinić M, Šinko G, Hrvat NM, et al. . Oxime-assisted reactivation of tabun-inhibited acetylcholinesterase analysed by active site mutations. Toxicology 2018;406–407:104–13. PubMed

Artursson E, Akfur C, Hörnberg A, et al. . Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis. Toxicology 2009;265:108–14. PubMed

Wei Z, Liu Y, Wang Y. Novel nonquaternary reactivators showing reactivation efficiency for soman-inhibited human acetylcholinesterase. Toxicol Res (Camb) 2016;30:246. PubMed

Searching for potential drugs against SARS-CoV-2 through virtual screening on several molecular targets

Molecular Modeling Studies on the Multistep Reactivation Process of Organophosphate-Inhibited Acetylcholinesterase and Butyrylcholinesterase

Reactivation of VX-Inhibited Human Acetylcholinesterase by Deprotonated Pralidoxime. A Complementary Quantum Mechanical Study

Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis